ECCO 2024:new therapy and strategies for Crohns disease
The 19th European Crohns and Colitis Organisation(ECCO)Annual Congress focused on"Cross-ing borders in inflammatory bowel disease".The congress unveiled advancements in new therapies,strategies,and treatment endpoints for inflammatory bowel disease.Highlighted at this year's ECCO congress were novel bi-ologic agents,efficacy studies on small molecule drugs,and safety analyses in the treatment of Crohn's disease.The treatment strategies for Crohn's disease incorporated new concepts,including inflammatory biomarkers cou-pled with"step-up"and"step-down"approaches,pharmacogenomics,surgical methods,and screening strategies for perianal fistula carcinoma,offering fresh perspectives for optimizing clinical treatments.This view discusses the new therapies and strategies presented at the conference,aiming to provide insights into research directions for Crohns dis-ease in our country.
NETL
NSTL
万方数据
